Alnylam Pharmaceuticals | 资产

Assets 更改 日
Acadia Pharmaceuticals USD 855.1M 106.15M 2024-03
Agios Pharmaceuticals USD 849.71M 87.41M 2024-03
Alnylam Pharmaceuticals USD 3.82B 5.49M 2024-03
Amgen USD 92.98B 4.17B 2024-03
Arrowhead Research USD 955.15M 328.86M 2024-03
Avrobio USD 92.35M 8.74M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Incyte USD 7.14B 353.5M 2024-03
Ionis Pharmaceuticals USD 2.76B 226.14M 2024-03
Moderna USD 16.73B 1.7B 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
Novartis USD 94.33B 5.61B 2024-03
PTC Therapeutics USD 1.79B 106.07M 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Sarepta Therapeutics USD 3.22B 114.68M 2024-03
Takeda JPY 14.22T 648.94B 2023-12
Ultragenyx Pharmaceutical USD 1.31B 183.93M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03
Xencor USD 884.26M 68.44M 2024-03



Alnylam Pharmaceuticals 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.